Literature DB >> 27460444

The biological role of epithelial-mesenchymal transition in lung cancer (Review).

Woo Jung Sung1, Hongtae Kim2, Kwan-Kyu Park1.   

Abstract

Epithelial-mesenchymal transition (EMT) is a process whereby epithelial cells gradually transform into mesenchymal-like cells losing their epithelial functionality and characteristics. EMT is thought to be involved in the pathogenesis of numerous lung diseases ranging from developmental disorders and fibrotic tissue remodeling to lung cancer. Lung cancer is the most lethal form of cancer worldwide, and despite significant therapeutic improvements, the patient survival rate still remains low. Activation of EMT endows invasive and metastatic properties upon cancer cells that favor successful colonization of distal target organs. The present review provides a brief insight into the mechanism and biological assessment methods of EMT in lung cancer and summarizes the recent literature highlighting the controversial experimental data and conclusions.

Entities:  

Mesh:

Year:  2016        PMID: 27460444     DOI: 10.3892/or.2016.4964

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  22 in total

1.  Increased expression of monoamine oxidase A is associated with epithelial to mesenchymal transition and clinicopathological features in non-small cell lung cancer.

Authors:  Fei Liu; Liang Hu; Yuefan Ma; Bingyu Huang; Zihan Xiu; Peihua Zhang; Keyuan Zhou; Xudong Tang
Journal:  Oncol Lett       Date:  2017-12-21       Impact factor: 2.967

2.  Snail acetylation by autophagy-derived acetyl-coenzyme A promotes invasion and metastasis of KRAS-LKB1 co-mutated lung cancer cells.

Authors:  Jang Hee Han; Yong Keon Kim; Hakhyun Kim; Jooyoung Lee; Myung Joon Oh; Sang Bum Kim; Minjee Kim; Kook Hwan Kim; Hyun Ju Yoon; Myung-Shik Lee; John D Minna; Michael A White; Hyun Seok Kim
Journal:  Cancer Commun (Lond)       Date:  2022-07-15

Review 3.  Modulation of retinoid signaling: therapeutic opportunities in organ fibrosis and repair.

Authors:  Suya Wang; Jianshi Yu; Maureen A Kane; Alexander R Moise
Journal:  Pharmacol Ther       Date:  2019-10-16       Impact factor: 12.310

Review 4.  Defining oligometastatic non-small cell lung cancer: concept versus biology, a literature review.

Authors:  Jill F Mentink; Marthe S Paats; Daphne W Dumoulin; Robin Cornelissen; Joris B W Elbers; Alexander P W M Maat; Jan H von der Thüsen; Anne-Marie C Dingemans
Journal:  Transl Lung Cancer Res       Date:  2021-07

5.  The A2B Adenosine Receptor Modulates the Epithelial- Mesenchymal Transition through the Balance of cAMP/PKA and MAPK/ERK Pathway Activation in Human Epithelial Lung Cells.

Authors:  Chiara Giacomelli; Simona Daniele; Chiara Romei; Laura Tavanti; Tommaso Neri; Ilaria Piano; Alessandro Celi; Claudia Martini; Maria L Trincavelli
Journal:  Front Pharmacol       Date:  2018-01-31       Impact factor: 5.810

6.  CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway.

Authors:  Bing Xu; Minjie Zhou; Wencai Qiu; Jueming Ye; Qiming Feng
Journal:  Cancer Med       Date:  2017-04-04       Impact factor: 4.452

7.  Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.

Authors:  Sung-Ying Huang; Shu-Fang Chang; Kuan-Fu Liao; Sheng-Chun Chiu
Journal:  Int J Mol Sci       Date:  2017-07-25       Impact factor: 5.923

8.  MicroRNA-320 inhibits cell proliferation and invasion in breast cancer cells by targeting SOX4.

Authors:  Jun-Wen Bai; Xia Wang; Ya-Feng Zhang; Guo-Dong Yao; Hong Liu
Journal:  Oncol Lett       Date:  2017-09-27       Impact factor: 2.967

9.  Effect of midkine on gemcitabine resistance in biliary tract cancer.

Authors:  Yongliang Lu; Bing Yan; Huihui Guo; Li Qiu; Xinrong Sun; Xiang Wang; Qian Shi; Ying Bao
Journal:  Int J Mol Med       Date:  2018-01-18       Impact factor: 4.101

10.  Network Pharmacology and Experimental Evidence Reveal Dioscin Suppresses Proliferation, Invasion, and EMT via AKT/GSK3b/mTOR Signaling in Lung Adenocarcinoma.

Authors:  Wenli Mao; Heng Yin; Wenya Chen; Tingxiu Zhao; Shaofeng Wu; He Jin; Biaoyan Du; Yuhui Tan; Ren Zhang; Yanli He
Journal:  Drug Des Devel Ther       Date:  2020-05-28       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.